Optimizing the HIV Prevention User Journey Tool: Applying a user-centered market research approach
As new HIV prevention products come to market, the need arose for a decision tool to support people to make informed choices about which product best fits their lifestyle and needs. The HIV Prevention user journey tool provides HIV prevention clients with information on the available and future methods and supports clients in their journey to select their most appropriate combination of HIV prevention methods. Specifically it supports adolescent girls and young women to select the most appropriate combination of HIV prevention methods and healthcare providers to provide optimized and informed counselling and information to clients seeking HIV prevention services.
This webinar will cover the process and findings from the market research assessment conducted to optimize the HIV Prevention User Journey Tool so that it is convenient, relevant and user-friendly for providers and clients.
Speakers
Elmari Briedenhann
PrEPpassionate and driven by a desire to meaningfully engage young people and the communities we serve. Elmari is a classically trained graphic designer with degrees in communication science and gender studies and is responsible for ensuring quality and evidence-informed approaches to demand generation, youth engagement, social and behavioral change communication, human centered-design and digital health technologies including AI, are applied to the work performed by the Implementation Science team at Wits RHI. Elmari is a Technical Head and leads the Innovation4Health team. She works across several implementation science projects focusing on HIV prevention with AGYW, ABYM and their communities, and is especially active in projects that drive the provision of PrEP.
Emily Donaldson
Emily Donaldson is a public health professional with public and private sector background in strategy development, market research and communication, and fifteen years’ experience in the infectious disease and sexual and reproductive health fields. She’s worked with pharmaceutical companies, including Merck, Johnson & Johnson, ViiV Healthcare, and Pfizer to lead global market research projects, including journeys, illuminations, brand strategy, and concept testing, for HIV, STIs, COVID-19, and women’s health products. Emily spent most of her career in the HIV prevention field, where she managed a portfolio of US Agency for International Development and Bill & Melinda Gates Foundation grants focused on driving demand and uptake for new HIV prevention products. Emily currently applies her passion for unearthing insights to inform product development and delivery to her role as a technical advisor for HIV prevention with FHI 360.
Admission
Free and open to all, online and in person. No registration required. A recording of this session will be available after the event on this page.
Contact
Admission
